# Cardiol Therapeutics Inc.: Form 20-F for the period ended Dec 31, 2023

- Company: [Cardiol Therapeutics Inc.](/companies/crdl.md) (CIK 1702123)
- Form: 20-F
- Filed: 2024-04-01
- Accepted by EDGAR: Apr 1, 2024, 17:15 ET
- Period: 2023-12-31
- Accession: 0001104659-24-041952
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1702123/000110465924041952/crdl-20231231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1702123/000110465924041952/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | −CAD 29.8m | ifrs-full:ProfitLossFromOperatingActivities |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | −CAD 28.1m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | −CAD 0.44 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | −CAD 0.44 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | −CAD 25.2m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | CAD 64.3k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2023-12-31 | CAD 34.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2023-12-31 | CAD 36.2m | ifrs-full:CurrentAssets |
| Total assets | at 2023-12-31 | CAD 36.7m | ifrs-full:Assets |
| Current liabilities | at 2023-12-31 | CAD 8.3m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2023-12-31 | CAD 8.5m | ifrs-full:Liabilities |
| Shareholders' equity | at 2023-12-31 | CAD 28.2m | ifrs-full:Equity |
| Shares outstanding | at 2023-12-31 | 65,352,279 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1702123/000110465924041952/crdl-20231231x20f.htm

Filed Apr 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-041952. Last ingested by Listed: Nov 3, 2026, 21:47 ET. No prices; not investment advice.